PAI Partners to Acquire Elemis from L’Occitane
The French private equity group announced on Wednesday that it will buy the UK skin and body care brand for an undisclosed sum.

In a world where younger consumers can summon a car or a meal at the click of a button, fashion houses are realising that their next generation of customers is not keen to wait six months for runway styles to hit store shelves.

The squeaky-clean specialty retailer has wooed back customers with a combination of great-fitting jeans, retail recalibration and smart marketing.

The bankrupt teen retailer is negotiating a potential sale to private equity firm Versa Capital Management that would save thousands of jobs and keep many of its stores open.

US teen retailer Aeropostale plans to challenge in court private equity firm Sycamore Partners' claims as a creditor in its bankruptcy, according to a transcript from a court hearing held this week.

As concert ‘merch’ becomes a more important part of their business models, pop stars like Justin Bieber, Kanye West and Rihanna are upping their game.

Today’s post-millennial teenagers have grown up with fundamentally different values, attitudes and consumer behaviours. BoF reports.
The French private equity group announced on Wednesday that it will buy the UK skin and body care brand for an undisclosed sum.
At its capital markets event in Shanghai, leadership said it aims to deliver mid-single-digit organic net sales growth through fiscal 2030, and unveiled a new cost-cutting and strategic roadmap.
The Indian beauty retailer said on Wednesday its second-quarter profit nearly tripled, as improved operating efficiency and strong demand for premium beauty products boosted margins.
The US retailer is planning to spin off its pharmacy business in what would be one of the biggest-ever breakups in the healthcare industry, according to reports.
The jeweller edged up its near-term revenue and profitability targets as efforts to keep the brand affordable pay off.
The Ozempic maker raised its full-year outlook for the third time this year on Wednesday as its Wegovy pill beat third-quarter sales forecasts, boosting the Danish firm's bid to win back ground from US rival Eli Lilly.
The fragrance firm reported third-quarter core profit a touch above market expectations on Wednesday, and raised its full-year growth outlook but failed to impress investors.
Sales and profit from clothing and homeware remain below two years ago but ‘brand is in good health.’